Mammalian EDG-7 receptor homologs
US6566096B2 · kind B2 · utility
2Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2000 |
| Grant date | May 20, 2003 |
| Priority date | — |
| Expiry date | Dec 7, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02W30/40
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is directed to nucleic acid sequence and amino acid sequences for mammalian EDG-7 receptor homologs, and particularly for human EDG-7 receptor homologs. The invention also provides methods for determining agonists and antagonsits for EDG-7 receptors in addition to assays, expression vectors, host cells and methods for treating disorders associated with abherrent expression or activity of EDG-7.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.